G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 49.6 HKD -1%
Market Cap: 50.3B HKD
Have any thoughts about
Giant Biogene Holding Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Giant Biogene Holding Co Ltd

Revenue
4.5B CNY
Cost of Revenue
-769.5m CNY
Gross Profit
3.7B CNY
Operating Expenses
-1.6B CNY
Operating Income
2.1B CNY
Other Expenses
-357m CNY
Net Income
1.8B CNY

Income Statement
Giant Biogene Holding Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2023 Jun-2024
Revenue
Revenue
3 524
N/A
4 459
+27%
Gross Profit
Cost of Revenue
(577)
(769)
Gross Profit
2 947
N/A
3 689
+25%
Operating Income
Operating Expenses
(1 281)
(1 564)
Selling, General & Administrative
(1 261)
(1 616)
Research & Development
(75)
(90)
Other Operating Expenses
56
141
Operating Income
1 667
N/A
2 125
+28%
Pre-Tax Income
Interest Income Expense
78
(0)
Non-Reccuring Items
1
(0)
Pre-Tax Income
1 745
N/A
2 125
+22%
Net Income
Tax Provision
(297)
(362)
Income from Continuing Operations
1 448
1 763
Income to Minority Interest
4
5
Net Income (Common)
1 452
N/A
1 768
+22%
EPS (Diluted)
1.48
N/A
1.74
+18%

See Also

Discover More